Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders | Embolism and Thrombosis, Venous Thrombosis, age-related macular degeneration, cardiovascular disorder, diabetic macular edema, eye disorder, macular degeneration, retinal degeneration, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorder, wet macular degeneration | Active, not recruiting | Phase 3 | 2026-04-22 | NCT05112861 |